Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2321138A vs Fluarix in Healthy Children
NCT00985790Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2009
- Primary completion
- May 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of influenza virus vaccine, quadrivalent, split virion in influenza (2 arms), sponsored by GSK. Primary endpoint: Titers for Serum Hemagglutination Inhibition (HI) Antibodies at Day 56. Started Oct 2009; status: completed.
02
Drugs
influenza virus vaccine, quadrivalent, split virion
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00985790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00985790.